Favorable Response to Intensity-Modulated Proton Therapy for Nasopharyngeal Non-Intestinal-Type Adenocarcinoma: A

Naoya Sanda1,2, Michi Sawabe1,2, Yoriko Yamashita3

  • 1Department of Otorhinolaryngology, Toyota Kosei Hospital, Toyota, Japan.

Head & Neck
|March 30, 2026
PubMed
Summary

Intensity-modulated proton therapy (IMPT) offers a promising treatment for rare nasopharyngeal non-intestinal-type adenocarcinoma (non-ITAC). This case study shows a complete tumor remission and sustained disease-free survival after IMPT.

Related Concept Videos